NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Start Multiple Choice Practice Test
Start Flash Cards

Practice this question and more.

In which patient population is Flibanserin (Addyi) indicated?

  1. Premenopausal females only

  2. Postmenopausal females

  3. All adults regardless of sex

  4. Adolescents

The correct answer is: Premenopausal females only

Flibanserin (Addyi) is indicated in premenopausal females only. It is specifically approved by the FDA for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women. HSDD is characterized by a lack of sexual desire that causes distress or interpersonal difficulty. Flibanserin works by affecting neurotransmitters in the brain to help increase sexual desire. This medication is not indicated for postmenopausal females, all adults regardless of sex, or adolescents, as its safety and efficacy have not been established in these populations.

More Questions Like This